Embozene Microspheres for Uterine Fibroid Embolization (UFE)

Inclusion Criteria: * Subject is able to provide informed consent and must sign the Institutional Review Board approved Informed Consent Form. * Pre-menopausal women age 30-50 years at time of enrollment * Have been selected forUterine Fibroid Embolization (UFE) prior to entry to the study. Exclusion Criteria: * Patient has a history of pelvic malignancy * Patient has an abnormal Pap smear within 12 months of the planned Uterine Fibroid Embolization procedure * Patient with coexisting condition that might explain abnormal bleeding (including endometrial hyperplasia and adenomyosis) or pelvic pain (including endometriosis and ovarian cysts). * Is at substantial risk for the need of organ transplantation, such as renal insufficiency. * Patient has evidence of current or recent pelvic inflammatory disease or uterine infection. * Patient with a severe contrast allergy or renal insufficiency that would represent a contradiction to the administration of iodine-based contrast agents. * Patients unable to comply with the follow-up requirements of the study.